Bannayan-Riley-Ruvalcaba syndrome epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Bannayan-Riley-Ruvalcaba syndrome}} {{CMG}}; {{AE}} {{VKG}} ==Overview== Incidence The incidence of Bannayan-Riley-Ruvalcaba syndrome is approximately 1 per 200...") |
|||
| Line 4: | Line 4: | ||
{{CMG}}; {{AE}} {{VKG}} | {{CMG}}; {{AE}} {{VKG}} | ||
==Overview== | ==Overview== | ||
The [[incidence]] of [[Bannayan-Riley-Ruvalcaba syndrome]] is approximately 1 per 200,000 individuals worldwide. [[Bannayan-Riley-Ruvalcaba syndrome]] commonly affects individuals of younger age. | |||
Incidence | == Epidemiology and Demographics == | ||
Prevalence | ===Incidence=== | ||
*The [[incidence]] of [[Bannayan-Riley-Ruvalcaba syndrome]] is approximately 1 per 200,000 individuals worldwide.<ref name="pmid26157835">{{cite journal |vauthors=Sagi SV, Ballard DD, Marks RA, Dunn KR, Kahi CJ |title=Bannayan Ruvalcaba Riley Syndrome |journal=ACG Case Rep J |volume=1 |issue=2 |pages=90–2 |date=January 2014 |pmid=26157835 |doi=10.14309/crj.2014.11 |url=}}</ref><ref name="pmid15667510">{{cite journal |vauthors=Schreibman IR, Baker M, Amos C, McGarrity TJ |title=The hamartomatous polyposis syndromes: a clinical and molecular review |journal=Am. J. Gastroenterol. |volume=100 |issue=2 |pages=476–90 |date=February 2005 |pmid=15667510 |doi=10.1111/j.1572-0241.2005.40237.x |url=}}</ref> | |||
Age | ===Prevalence=== | ||
Bannayan-Riley-Ruvalcaba syndrome commonly affects individuals of younger age. | *The [[prevalence]] of ''[[PTEN (gene)|PTEN]]'' mutations [[Bannayan-Riley-Ruvalcaba syndrome]] is approximately 65%. | ||
==='''Age'''=== | |||
*[[Bannayan-Riley-Ruvalcaba syndrome]] commonly affects individuals of younger age.<ref name="pmid19321504">{{cite journal |vauthors=Lynch NE, Lynch SA, McMenamin J, Webb D |title=Bannayan-Riley-Ruvalcaba syndrome: a cause of extreme macrocephaly and neurodevelopmental delay |journal=Arch. Dis. Child. |volume=94 |issue=7 |pages=553–4 |date=July 2009 |pmid=19321504 |doi=10.1136/adc.2008.155663 |url=}}</ref><ref name="pmid25549896">{{cite journal |vauthors=Busa T, Milh M, Degardin N, Girard N, Sigaudy S, Longy M, Olshchwang S, Sobol H, Chabrol B, Philip N |title=Clinical presentation of PTEN mutations in childhood in the absence of family history of Cowden syndrome |journal=Eur. J. Paediatr. Neurol. |volume=19 |issue=2 |pages=188–92 |date=March 2015 |pmid=25549896 |doi=10.1016/j.ejpn.2014.11.012 |url=}}</ref> | |||
*The [[median]] [[age]] for [[Bannayan-Riley-Ruvalcaba syndrome]] [[diagnosis]] is as young as five years | |||
==References== | ==References== | ||
Latest revision as of 16:21, 28 February 2019
Template:Bannayan-Riley-Ruvalcaba syndrome
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S [2]
Overview
The incidence of Bannayan-Riley-Ruvalcaba syndrome is approximately 1 per 200,000 individuals worldwide. Bannayan-Riley-Ruvalcaba syndrome commonly affects individuals of younger age.
Epidemiology and Demographics
Incidence
- The incidence of Bannayan-Riley-Ruvalcaba syndrome is approximately 1 per 200,000 individuals worldwide.[1][2]
Prevalence
- The prevalence of PTEN mutations Bannayan-Riley-Ruvalcaba syndrome is approximately 65%.
Age
- Bannayan-Riley-Ruvalcaba syndrome commonly affects individuals of younger age.[3][4]
- The median age for Bannayan-Riley-Ruvalcaba syndrome diagnosis is as young as five years
References
- ↑ Sagi SV, Ballard DD, Marks RA, Dunn KR, Kahi CJ (January 2014). "Bannayan Ruvalcaba Riley Syndrome". ACG Case Rep J. 1 (2): 90–2. doi:10.14309/crj.2014.11. PMID 26157835.
- ↑ Schreibman IR, Baker M, Amos C, McGarrity TJ (February 2005). "The hamartomatous polyposis syndromes: a clinical and molecular review". Am. J. Gastroenterol. 100 (2): 476–90. doi:10.1111/j.1572-0241.2005.40237.x. PMID 15667510.
- ↑ Lynch NE, Lynch SA, McMenamin J, Webb D (July 2009). "Bannayan-Riley-Ruvalcaba syndrome: a cause of extreme macrocephaly and neurodevelopmental delay". Arch. Dis. Child. 94 (7): 553–4. doi:10.1136/adc.2008.155663. PMID 19321504.
- ↑ Busa T, Milh M, Degardin N, Girard N, Sigaudy S, Longy M, Olshchwang S, Sobol H, Chabrol B, Philip N (March 2015). "Clinical presentation of PTEN mutations in childhood in the absence of family history of Cowden syndrome". Eur. J. Paediatr. Neurol. 19 (2): 188–92. doi:10.1016/j.ejpn.2014.11.012. PMID 25549896.